Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001968202-24-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-15 | 2024-03-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $399.66 | +20.0K | 68.3K | +41% | +$7.99M |
| DM | 2024-03-15 | 2024-03-14 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $956.47 | -5,783 | 52.9K | -10% | -$5.53M |
| D | 2024-03-15 | 2024-03-13 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $971.82 | -14.2K | 54.1K | -21% | -$13.82M |
| D | 2024-03-15 | 2024-03-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -20.0K | 20.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | M | A | 20,000 | $399.66 | 68,306 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-14 | S | D | 196 | $968.20 | 48,306 | D | — | — | (F12) Represents volume-weighted average price of sales of 196 shares of Company stock on March 14, 2024 at prices ranging from $968.15 to $968.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-03-14 | S | D | 17 | $966.30 | 48,502 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-14 | S | D | 78 | $965.51 | 48,519 | D | — | — | (F11) Represents volume-weighted average price of sales of 78 shares of Company stock on March 14, 2024 at prices ranging from $965.26 to $965.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-03-14 | S | D | 1 | $962.87 | 48,597 | D | — | — | |
| 6 | Common | Common Stock | 2024-03-14 | S | D | 47 | $961.74 | 48,598 | D | — | — | |
| 7 | Common | Common Stock | 2024-03-14 | S | D | 512 | $959.36 | 48,645 | D | — | — | (F10) Represents volume-weighted average price of sales of 512 shares of Company stock on March 14, 2024 at prices ranging from $959.13 to $959.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-03-14 | S | D | 477 | $958.34 | 49,157 | D | — | — | (F9) Represents volume-weighted average price of sales of 477 shares of Company stock on March 14, 2024 at prices ranging from $958.06 to $958.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-03-14 | S | D | 730 | $957.35 | 49,634 | D | — | — | (F8) Represents volume-weighted average price of sales of 730 shares of Company stock on March 14, 2024 at prices ranging from $957.02 to $957.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 10 | Common | Common Stock | 2024-03-14 | S | D | 1,108 | $956.34 | 50,364 | D | — | — | (F7) Represents volume-weighted average price of sales of 1,108 shares of Company stock on March 14, 2024 at prices ranging from $956.08 to $956.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 11 | Common | Common Stock | 2024-03-14 | S | D | 545 | $955.54 | 51,472 | D | — | — | (F6) Represents volume-weighted average price of sales of 545 shares of Company stock on March 14, 2024 at prices ranging from $955.02 to $955.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 12 | Common | Common Stock | 2024-03-14 | S | D | 870 | $954.66 | 52,017 | D | — | — | (F5) Represents volume-weighted average price of sales of 870 shares of Company stock on March 14, 2024 at prices ranging from $954.01 to $954.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 13 | Common | Common Stock | 2024-03-13 | F | D | 14,217 | $971.82 | 54,089 | D | — | — | |
| 14 | Common | Common Stock | 2024-03-14 | S | D | 182 | $951.92 | 53,907 | D | — | — | (F2) Represents volume-weighted average price of sales of 182 shares of Company stock on March 14, 2024 at prices ranging from $951.89 to $951.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 15 | Common | Common Stock | 2024-03-14 | S | D | 444 | $952.40 | 53,463 | D | — | — | (F3) Represents volume-weighted average price of sales of 444 shares of Company stock on March 14, 2024 at prices ranging from $952.00 to $952.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 16 | Common | Common Stock | 2024-03-14 | S | D | 576 | $953.77 | 52,887 | D | — | — | (F4) Represents volume-weighted average price of sales of 576 shares of Company stock on March 14, 2024 at prices ranging from $953.30 to $953.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 14, 2024 at each separate price. |
| 17 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-03-13 | M | D | 20,000 | $0.00 | 20,000 | D | $399.66 · — to 2024-12-16 | 20,000 Common Stock | (F13) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |